Found 66 matching trials
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma PHASE1 RATIONALE: Vaccines made from white blood cells treated with antigens may m...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Melanoma PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma PHASE2 This experiment will test the safety and effectiveness of a treatment for m...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Metastatic Melanoma PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Learn More & Join Trial
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma PHASE1 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma PHASE2 This randomized phase II trial is studying how well giving vaccine therapy ...
Show More Location
National Cancer Institute Surgery Branch
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Learn More & Join Trial
Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma PHASE2 RATIONALE: Vaccines made from peptides that are found on melanoma cells may...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma PHASE2 This randomized phase II trial is studying how well giving vaccine therapy ...
Show More Location
University of Chicago Comprehensive Cancer Center
Learn More & Join Trial